[go: up one dir, main page]

PT91719A - Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino - Google Patents

Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino

Info

Publication number
PT91719A
PT91719A PT91719A PT9171989A PT91719A PT 91719 A PT91719 A PT 91719A PT 91719 A PT91719 A PT 91719A PT 9171989 A PT9171989 A PT 9171989A PT 91719 A PT91719 A PT 91719A
Authority
PT
Portugal
Prior art keywords
derivatives
growth factor
bfgf
fobroblast
new human
Prior art date
Application number
PT91719A
Other languages
English (en)
Other versions
PT91719B (pt
Inventor
Paolo Sarmientos
Laura Bergonzoni
Antonella Isacchi
Gilles Cauet
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of PT91719A publication Critical patent/PT91719A/pt
Publication of PT91719B publication Critical patent/PT91719B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/503Fibroblast growth factor [FGF] basic FGF [bFGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Eye Examination Apparatus (AREA)
PT91719A 1988-09-16 1989-09-14 Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino PT91719B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821795A GB8821795D0 (en) 1988-09-16 1988-09-16 New derivatives of human/bovine basic fibroplast growth factor

Publications (2)

Publication Number Publication Date
PT91719A true PT91719A (pt) 1990-03-30
PT91719B PT91719B (pt) 1995-05-31

Family

ID=10643728

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91719A PT91719B (pt) 1988-09-16 1989-09-14 Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino

Country Status (21)

Country Link
EP (2) EP0396664A1 (pt)
JP (1) JP2888575B2 (pt)
KR (1) KR900702027A (pt)
CN (1) CN1041181A (pt)
AT (1) ATE98693T1 (pt)
AU (1) AU620925B2 (pt)
CA (1) CA1340834C (pt)
DE (1) DE68911461T2 (pt)
DK (1) DK120290A (pt)
ES (1) ES2061855T3 (pt)
FI (1) FI902391A0 (pt)
GB (1) GB8821795D0 (pt)
HU (1) HUT53937A (pt)
IL (1) IL91615A0 (pt)
MY (1) MY104910A (pt)
NO (1) NO902176L (pt)
NZ (1) NZ230621A (pt)
PT (1) PT91719B (pt)
WO (1) WO1990002800A1 (pt)
YU (1) YU179489A (pt)
ZA (1) ZA897020B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143829A (en) * 1990-03-29 1992-09-01 California Biotechnology Inc. High level expression of basic fibroblast growth factor having a homogeneous n-terminus
US5478804A (en) * 1990-09-19 1995-12-26 The Salk Institute For Biological Studies Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates
JP3135138B2 (ja) * 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
US6833354B1 (en) 1990-12-19 2004-12-21 Kaken Pharmaceutical Co., Ltd. Agent for the treatment of bone diseases
EP0505108B1 (en) * 1991-03-21 1995-10-18 The Procter & Gamble Company Compositions for regulating skin wrinkles comprising an Arg-Ser-Arg-Lys based peptide
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 bFGFムテインおよびその製造法
TW275068B (pt) * 1993-09-24 1996-05-01 American Cyanamid Co
AUPO247496A0 (en) 1996-09-23 1996-10-17 Resmed Limited Assisted ventilation to match patient respiratory need
US6214795B1 (en) 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
FR2780416B1 (fr) * 1998-06-10 2002-12-20 Rhone Poulenc Nutrition Animal Procede industriel de production de proteines heterologues chez e. coli et souches utiles pour le procede
JP5704780B2 (ja) 1999-08-13 2015-04-22 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 脈管形成因子の用量および心筋血流を改善するための投与方法
AU2376000A (en) * 1999-12-22 2001-07-03 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor
CA2430112C (en) 2000-11-27 2010-07-27 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and use thereof
WO2013090919A1 (en) * 2011-12-16 2013-06-20 Wisconsin Alumni Research Foundation Fgf-2 having enhanced stability
CN106957359B (zh) * 2016-08-31 2020-04-24 黄志锋 Fgf1突变体及其医药应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000198A1 (en) * 1987-07-07 1989-01-12 Biotechnology Research Associates, J.V. Recombinant fibroblast growth factors
IL81839A0 (en) * 1986-03-14 1987-10-20 Takeda Chemical Industries Ltd Polypeptide,dna and its use
JPH01501840A (ja) * 1987-01-16 1989-06-29 アムジエン・インコーポレーテツド 繊維芽細胞成長因子の産生
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン,dnaおよびその用途
EP0326907A1 (en) * 1988-01-26 1989-08-09 Takeda Chemical Industries, Ltd. Polypeptide, DNA and its use

Also Published As

Publication number Publication date
DE68911461T2 (de) 1994-05-19
EP0363675A1 (en) 1990-04-18
HU895573D0 (en) 1990-11-28
IL91615A0 (en) 1990-04-29
NO902176L (no) 1990-07-13
DE68911461D1 (de) 1994-01-27
WO1990002800A1 (en) 1990-03-22
CA1340834C (en) 1999-11-30
EP0396664A1 (en) 1990-11-14
KR900702027A (ko) 1990-12-05
FI902391A7 (fi) 1990-05-14
AU4317189A (en) 1990-04-02
FI902391A0 (fi) 1990-05-14
CN1041181A (zh) 1990-04-11
DK120290D0 (da) 1990-05-15
MY104910A (en) 1994-06-30
NZ230621A (en) 1992-06-25
NO902176D0 (no) 1990-05-15
DK120290A (da) 1990-07-16
AU620925B2 (en) 1992-02-27
ATE98693T1 (de) 1994-01-15
YU179489A (en) 1991-10-31
ES2061855T3 (es) 1994-12-16
ZA897020B (en) 1990-08-29
EP0363675B1 (en) 1993-12-15
JP2888575B2 (ja) 1999-05-10
PT91719B (pt) 1995-05-31
JPH03501855A (ja) 1991-04-25
HUT53937A (en) 1990-12-28
GB8821795D0 (en) 1988-10-19

Similar Documents

Publication Publication Date Title
PT91719A (pt) Processo para a preparacao de novos derivados de factor de crescimento de fobroblastos basico humano/bovino
PT92278A (pt) Processo para a preparacao de proteinas de ligacao de factor de crescimento semelhante a insulina
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
SG49097A1 (en) Nucleotide sequences coding for a protein with urease activity
ATE107958T1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
PL322945A1 (en) Novel protein and method of obtaining same
DE3750197D1 (de) Antagonisten des Fibroblasten-Wachstumsfaktors.
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
ATE123949T1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
ATE90944T1 (de) Fuer ein hirudinaehnliches protein kodierende dns- sequenz und verfahren zur herstellung eines solchen proteins.
PT92603A (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
DE3850654D1 (de) Immunglobulin-e-kompetitor.
DE3854420D1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
FI102383B1 (fi) Menetelmä ja plasmidi modifioidun PE40-domeenia sisältävän hybridiproteiinin valmistamiseksi
EP0315118A3 (en) Dna coding for endothelin and use thereof
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
PT704527E (pt) Sequencias de adn que codificam precursores de insulina biossinteticos e processo para a preparacao de insulina
ES2044887T3 (es) Metodo para la preparacion de factor de crecimiento de tipo insulina i.
DE3856392D1 (de) Klonierung von Malaria-spezifischen DNA-Sequenzen:Isolierung des Gens für das 140 kd Protein
DE3900770A1 (de) Verfahren zur herstellung von pdgf-a und pdgf-aa
ATE158814T1 (de) Verfahren zur gentechnologischen herstellung von biologisch aktivem beta-ngf
Bergonzoni et al. Deletion mutant of basic fibroblast growth factor and production thereof
ATE130872T1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
ATE107694T1 (de) Für a.nidulans-isopenicillin-n-synthetase codierende dns, deren verwendung und dafür codierende vektoren.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941114

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960531